openPR Logo
Press release

Global Balsalazide Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028

03-24-2022 12:06 PM CET | Health & Medicine

Press release from: Orion Market Reseach

The global balsalazide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Balsalazide is an anti-inflammatory drug. It is converted in the body to mesalamine and works by reducing the prevalence of bowel inflammation such as Crohn's disease and ulcerative colitis, rectal bleeding, and stomach pain. According to the data published by National Center for Biotechnology Information in 2021, ulcerative colitis is estimated to have an incidence of 9 to 20 cases per 10,000 persons annually. Similarly, its prevalence is estimated at 156 to 269 cases per 10,000 persons annually. Moreover, ulcerative colitis has a bimodal pattern of incidence. According to the same source, the main peak of incidence occurs between the age of 15 and 30 years, and a smaller peak of incidence occurs between the age of 50 and 70 years. Thus, the rise in the incidence of ulcerative colitis across the globe is anticipated to drive the demand of the global balsalazide market during the forecast period.
According to the data published by Crohn's & Colitis Foundation of America (CCFA) in 2019, approximately 1.6 million Americans suffer from Inflammatory Bowel Disease (IBD) out of which 80000 children are expected to have IBD. Further, 70,000 new cases of IBD are diagnosed in the US annually. Moreover, Crohn's disease and ulcerative diseases are chronic illnesses and changes are likely to occur over time. For instance, as per the same source, 50.0% of the patients suffering from Crohn's disease will have mild disease over the next five years. 45% of those will remain relapse-free over the next year and 35.0% will have one or two relapses. Thus, for a Crohn's disease patient in remission, the relapses rate at one, two, five, and ten years are estimated at 20.0%, 40.0%,67.0%, and 76.0% respectively. Thus, the rise in the prevalence of IBD across the globe is anticipated to drive the growth of the balsalazide market globally.
Looking towards the demand for balsalazide key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2021, Sanofi SA agreed to divest an integrated portfolio of anti-inflammatory drugs to Fidia Farmaceutici. The agreement covers the registrations, trademarks, and related commercial rights of products including non-steroidal anti-inflammatory drugs across Europe and the emerging market. This agreement is aimed at streamlining and simplifying its portfolio by enhancing profitability.
Further, in May 2021, Bristol Myers Squibb has received the US FDA approval for Zeposia (ozanimod), for the treatment of adults with moderately to severely active ulcerative colitis (UC), a chronic IBD. Moreover, the Zeposia 360 degree support program will facilitate access to Zeposia for appropriate patients with ulcerative colitis (UC). In addition, in June 2020, Takeda pharmaceuticals announced that the USFDA has approved the company's submission for its biological manufacturing facility in Brooklyn, for the production of Entyvio (vedolizumab) drug substance. Entyvio is used for the treatment of gastrointestinal diseases such as ulcerative colitis and Crohn's disease. Thus, the establishment of a manufacturing facility aimed to serve patients suffering from moderately to severly active ulcerative coltis and Crohn's disease in the US and globally. Therefore, such launches coupled with approvals are anticipated to drive the growth of the global balsalazide market during the forecast period.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Balsalazide Market at:

Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Rest of the World
Competitive Landscape- Salix Pharmaceuticals (Bausch Health),Bristol-Myers Squibb Co., and Takeda Pharmaceutical Co Ltd among others .

A full report is available at:

Global Balsalazide Market Report by Segment
By Type
By Application
Drug store
Online Pharmacy
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Balsalazide Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028 here

News-ID: 2585951 • Views: 183

More Releases from Orion Market Reseach

Hybrid PV Inverter Market to Witness Robust Expansion by 2028
In order to form Hybrid PV Inverter Market research report, market analysts do comprehensive market study and points out exact causes of sales decrease as well as reasons behind it. It further helps to decide on the exact problem source and provides ways to deal with it. For making business financially stable, decision making has great significance. In this regard, referring Hybrid PV Inverter Market study report is important as
Aquarium Filters Market Top Leading Players with Strategies and Forecast 2028
Aquarium Filters Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Aquarium Filters market with a focus on the market. Key Players Aqua Design Amano (JP) EHEIM (DE) Marukan (JP) Den Marketing (UK) Clear-Seal (UK) Waterlife (UK)   By Type Self-Cleaning Filter Automatic Filter Stainless Steel Brush Filter   By Application Store Aquarium Household Other  Scope of the Report The research study analyses the Aquarium Filters Market from 360-degree analysis of the market thoroughly delivering insights into the market for better
Aquaculture Automatic Feeding Machines Market Top Leading Players with Strategie …
Aquaculture Automatic Feeding Machines Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Aquaculture Automatic Feeding Machines market with a focus on the market. The report provides key statistics on market of Aquaculture Automatic Feeding Machines. It is a valuable source of guidance and direction for companies and individuals interested in Aquaculture Automatic Feeding Machines industry. Key Players Aquaculture Equipment Ltd Pioneer A.E.
Global Anastrozole Tablets Market Top Leading Players with Strategies and Foreca …
The global anastrozole tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rising incidence of breast cancer among the population across the globe is primary factor contributing towards the growth of the market. Anastrozole tablets are primarly used to used for hormone receptor-positive breast cancer. It is also been used to prevent breast cancer in women which are at high risk of menopause. According to the

All 5 Releases

More Releases for Crohn

Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the
Crohns Disease Drug Market 2020 Recent Industry Developments and Growth Strateg …
ReportsnReports provides in depth study of "Crohns Disease Drug Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Crohns Disease Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organisation such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organisation. The global
Crohns Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Order a Copy of
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025. This study answers several questions for stakeholders, primarily which market segments
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson Pfizer Sanofi Merck GSK AbbVie Takeda Ferring UCB Boehringer Ingelheim Ask for sample copy @ Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Crohn Disease can be split into Small Intestine and Ileocephalitis Colon Disease Market segment